Artificial Intelligence
NVIDIA Expands Reach With New GeForce Laptops and Desktops, GeForce NOW Partners, and Omniverse for Creators
160+ Gaming and Studio Laptop Designs, GeForce RTX 3080 Ti for Laptops and RTX 3050 for Desktops; More Electronic Arts Games, Samsung TVs and AT&T Join GeForce NOW; Omniverse Extended to Millions of Creators
SANTA CLARA, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) — CES—NVIDIA today set out the next direction of the ultimate platform for gamers and creators, unveiling more than 160 gaming and Studio GeForce®-based laptop designs, as well as new desktop and laptop GeForce RTX® GPUs and technologies.
The company also announced new RTX-accelerated content, and the expansion of both GeForce NOW™ cloud gaming and the NVIDIA Studio ecosystem, including the launch of NVIDIA Omniverse™ for creators.
“GeForce RTX is transforming gaming and opening up vast digital worlds. Today’s announcements further establish GeForce as the ultimate platform for gamers and creators,” said Jeff Fisher, senior vice president of consumer products at NVIDIA. “And GeForce NOW continues to grow as our platform for reaching billions of gamers.”
GeForce RTX Powering 160+ New Laptops
The world’s top manufacturers are bringing to market more than 160 gaming and Studio laptops based on the revolutionary NVIDIA Ampere architecture, with second-generation RT Cores for ray tracing and third-generation Tensor Cores for DLSS and AI, creating the thinnest, lightest and most powerful laptops ever.
Based on the latest generation of CPUs, these laptops offer a wide range of form factors, such as dual screens, easels, convertibles, and 14-inch screens, many sporting G-SYNC® and 1440p displays.
RTX 3080 Ti and RTX 3070 Ti Deliver New Levels of Performance
NVIDIA’s launch of the GeForce RTX 3080 Ti laptop GPU brings the flagship 80 Ti class of GPUs to laptops for the first time. Featuring 16GB of the fastest GDDR6 memory ever shipped in a laptop, the RTX 3080 Ti delivers higher performance than the desktop NVIDIA TITAN RTX™. RTX 3080 Ti laptops start at $2,499.
The new GeForce RTX 3070 Ti is up to 70 percent faster than RTX 2070 SUPER laptops and can deliver 100 frames per second at 1440p resolution. RTX 3070 Ti laptops start at $1,499.
Laptops powered by both of these new GPUs will be available starting on Feb. 1.
NVIDIA also introduced the fourth generation of Max-Q technologies, which have revolutionized laptop performance since their introduction four years ago. These features include CPU Optimizer, Rapid Core Scaling and Battery Boost 2.0, which further enhance efficiency, performance and battery life.
New NVIDIA Studio Laptops and Apps
NVIDIA is further expanding its Studio platform of hardware, software and exclusive applications that helps creators get from concept to completion faster.
This includes a major update to NVIDIA Canvas, a painting application that uses AI to generate landscape images from simple brush strokes. Built from NVIDIA’s GauGAN2® research, the app produces images that are 4x higher resolution than in the past, with five additional elements like flowers and bushes. The new Canvas app is free to download.
The Studio platform also includes a wide range of NVIDIA Studio laptops, with designs from ASUS, MSI and Razer powered by the new GeForce RTX 3080 Ti and 3070 Ti laptop GPUs. With the latest RTX GPUs, these laptops are on average 7x faster for 3D rendering than the latest MacBook Pro 16.(1) They support more than 200 creative applications, as well as RTX-accelerated ray tracing, AI and NVIDIA’s high-performance video processor, making them the perfect tool for any creator workflow.
NVIDIA Omniverse Launches For Creators
Further enriching the NVIDIA Studio ecosystem, NVIDIA Omniverse is now available at no cost to millions of individual creators with GeForce RTX and NVIDIA RTX GPUs. NVIDIA’s real-time 3D design collaboration and virtual world simulation platform empowers artists, designers and creators to connect and collaborate in leading design applications from their RTX-powered laptop or workstation.
A new platform feature, Omniverse Nucleus Cloud, is enabling simple “one-click-to-collaborate” sharing of large Omniverse 3D scenes. Artists can collaborate in real time from across the room or the globe without transferring massive datasets.
NVIDIA also introduced new platform developments for Omniverse Machinima — the Omniverse app that enables real-time collaboration to animate and manipulate characters in virtual worlds — with additional free game characters, objects and environments. Omniverse Audio2Face, which quickly and easily generates expressive facial animation from just an audio source, has been updated with blendshape support and direct export to Epic’s MetaHuman.
Introducing the New GeForce RTX 3050
NVIDIA further expanded its family of NVIDIA Ampere architecture-based GPUs with the GeForce RTX 3050.
Bringing the performance and efficiency of the architecture to more gamers than ever, the RTX 3050 is the first 50-class desktop GPU to power the latest ray-traced games at over 60 frames per second. RTX 3050 makes ray tracing, which is the new standard in gaming, more accessible than ever before.
With 75 percent of gamers still playing on GTX GPUs, the 3050, which also includes second-generation RT cores as well as third generation Tensor cores for DLSS and AI, represents a compelling upgrade opportunity to step up to RTX.
The RTX 3050, which comes with 8GB of GDDR6 memory, starts at just $249 and will be available on Jan. 27 from NVIDIA’s worldwide partners.
New NVIDIA RTX Titles, Including New Ray Tracing, DLSS and Reflex Integrations
NVIDIA announced 10 new RTX games, which use GPU-accelerated ray tracing, NVIDIA DLSS and NVIDIA Reflex gaming technologies to provide new levels of realism. The new titles include The Day Before, Escape from Tarkov and the highly anticipated Ubisoft title Rainbow Six Extraction.
NVIDIA also announced seven new integrations of NVIDIA Reflex, its low-latency gaming platform, which better connects the player to the game.
The new Reflex games include iRacing, the world’s premier online racing simulator, Ubisoft’s Rainbow Six Extraction, and Sony’s award-winning, fighting-based action-adventure game God of War.
A New Monitor Category – 1440p Esports
With the global growth in esports, the demand for esports displays has been doubling each year. 1080p displays have ruled esports for over a decade — as the lower resolution has enabled higher frame rates and faster refresh rates. With today’s top GeForce RTX GPUs rendering esports games well above 360 fps at 1440p, the industry is primed for a change.
NVIDIA Research found that 1440p 27-inch displays can improve aiming by up to 3 percent over traditional 1080 24-inch displays when aiming at small targets. For competitive games where every millisecond counts, 3 percent can often make the difference between victory and defeat.
NVIDIA announced four new displays in the 1440p esports category. The ASUS ROG Swift 360Hz PG27AQN features a 360Hz refresh rate. The AOC AG274QGM – AGON PRO Mini LED, MSI MEG 271Q Mini LED, and ViewSonic XG272G-2K Mini LED all feature mini-LED with a 300Hz refresh rate. All come with NVIDIA Esports Vibrance, Dual-Format and Reflex Analyzer features.
NVIDIA Reflex Ecosystem Expands
Over 20 million GeForce gamers compete with Reflex each month. As the popularity of the Reflex platform grows, so does the Reflex hardware ecosystem. NVIDIA announced six new Reflex monitors and six new Reflex mice.
There are now over 50 Reflex mice and monitors from 16 partners — all utilizing the Reflex Latency Analyzer, which allows gamers to easily measure system latency with a single click of the mouse.
GeForce NOW: The Ultimate Cloud Gaming Platform for PC Gamers
More games, more devices and improved networks are being delivered to the GeForce NOW ecosystem. Today NVIDIA announced the extension of its partnership with Electronic Arts, bringing Battlefield 4 and Battlefield V to GeForce NOW, streaming today.
NVIDIA also announced a partnership with Samsung to integrate GeForce NOW in its Smart TVs, starting in Q2 of this year. This follows last month’s beta release of the GeForce NOW app for LG 2021 WebOS Smart TVs. Teaming with AT&T as a 5G Technical Innovation partner, GeForce NOW is bringing the power of PC gaming to mobile devices. Starting in January, AT&T customers with a 5G device on a 5G unlimited plan, or qualifying unlimited plan, can get a six-month GeForce NOW Priority membership at no charge.(2)
For press assets, visit www.nvidia-press.com.
About NVIDIA
NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market and has redefined modern computer graphics, high performance computing and artificial intelligence. The company’s pioneering work in accelerated computing and AI is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others. More information at https://nvidianews.nvidia.com/.
For further information, contact:
Kelly Musgrave
Senior Manager PR, GeForce
NVIDIA Corporation
+1-650-421-3748
[email protected]
(1) Render times measured in Autodesk Arnold, Blender Cycles 3.0, Chaos V-Ray GPU, OctaneRender, and Redshift. Studio laptop equipped with GeForce RTX 3080 Ti, 12th gen Intel Core processors, 32GB RAM, Windows 11, NVIDIA Driver 510.50. Macbook Pro 16 equipped with M1 Max and 32GB RAM.
(2) Subject to change. Restrictions apply. See att.com/gaming for more details.
Certain statements in this press release including, but not limited to, statements as to: the performance, features, benefits, impact, and availability of our products and technologies, including GeForce RTX GPUs, NVIDIA Omniverse, GeForce NOW, the NVIDIA Studio ecosystem, NVIDIA Canvas, NVIDIA RTX, and NVIDIA Reflex; GeForce RTX transforming gaming and opening up vast digital worlds; GeForce NOW continuing to grow as our platform for reaching billions of gamers; the global growth in esports; the popularity of the Reflex platform growing; and more games, more devices and improved networks being delivered to the GeForce NOW ecosystem are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.
© 2022 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, GauGAN2, GeForce, GeForce NOW, GeForce RTX, G-SYNC, NVIDIA Omniverse and NVIDIA TITAN RTX are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. MAXQ is the registered trademark of Maxim Integrated Products. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability and specifications are subject to change without notice.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/20be2915-2a92-42d9-9bf9-b3009213a067
USA News Group Commentary
VANCOUVER, BC, April 25, 2024 /PRNewswire/ — Across several sectors the use of artificial intelligence (AI) is making a huge impact, with healthcare emerging as possibly receiving the largest boost. According to a new research report from analysts at Mordor Intelligence, the market for artificial intelligence in health care is set to explode at a CAGR of 42.20% through 2029. As the tech sector races to provide the market with solutions, several companies are emerging as leaders in aiding the healthcare sector, including Avant Technologies Inc. (OTC:AVAI), Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT), Health Catalyst, Inc. (NASDAQ:HCAT), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), and Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX).
Recently, Avant Technologies Inc. (OTC:AVAI) strengthened its AI-powered healthcare offerings by acquiring Wired-4-Health, a company specializing in healthcare technology and data services. This addition supports Avant’s goal to create the first supercomputing network in the country. This network will offer big data and AI software companies a quicker, more potent, and more affordable computing infrastructure.
“Our strategy behind this acquisition was to enable Avant to deliver best-in-class data and system interoperability support services to the healthcare and life sciences sectors powered by AvantAI® and our high-density compute capabilities,” said Tim Lantz, CEO of Avant Technologies. “At the same time, this exciting combination significantly strengthens our financial profile, offers massive commercial growth opportunities in one of Avant’s largest target markets, and bolsters our internal customer support and R&D capabilities.”
The goal of this deal is to bring together Avant Technologies and Wired-4-Health to improve how healthcare data is shared and used. By joining forces, they can use advanced AI and powerful computing to help healthcare and life sciences organizations deal with data and system challenges more easily and effectively.
This partnership improves the way transactions are processed, analyzes health outcomes, and ensures compliance, leading to better performance, more reliable data, and a more affordable, scalable system for customers.
“In the near term, if the healthcare industry expects to succeed in lowering costs while improving quality, the deployment of advanced AI, combined with more powerful, cost- effective compute capabilities will be critical to that success,” said Angela Harris, Avant’s Chief Operating Officer. “The addition of Wired-4-Health will position Avant as a key contributor in helping healthcare organizations solve complex problems at the intersection of cost, quality, compliance and technology.”
Tech giant Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT) has also been aiding the healthcare sector, most notably with its Azure AI Health Bot, which helps create copilot experiences with healthcare safeguards. Microsoft is enhancing its Azure AI Health Bot services by adding new healthcare-specific safeguards and features, including integration with Microsoft Copilot Studio.
These upgrades allow healthcare organizations to create their own copilot experiences, with pre-built capabilities, templates, and connectors tailored to healthcare needs, supporting protocol-based workflows alongside AI-based answers, and ensuring compliance with industry standards and guidelines. Now the platform is already being put into use by big players, including by German pharma giant Roche.
“By leveraging Azure AI Health Bot to build copilot experiences for doctors, we are developing an intuitive, conversational interface that lets clinicians access and explore Roche’s clinical documentations in a more natural way and to cope with the complexity and flood of information,” said Dr. Georg Isbary of Roche Pharma Germany. “The pilot for this new user experience, powered by generative AI features and compliant with the necessary security standards, has been integrated into our systems and will be further tailored to regional market needs.”
Long-time developer in the AI and machine learning (ML) space for healthcare, Health Catalyst, Inc. (NASDAQ:HCAT) signed a multi-year partnership with SacValley MedShare, one of California’s largest and most established qualified health information organization, earlier this year. As per the deal, Health Catalyst will support SacValley’s important mission through a broad set of technology solutions, including KPI Ninja by Health Catalyst, Healthcare.AI – a Health Catalyst Data Operating System (DOSTM) Platform module, and several other application solutions and Professional Services.
“We are honored to partner with SacValley MedShare on their continued journey to advance healthcare and are confident our technology, combined with our dedicated, skilled team members, will deliver the improved efficiency and support SacValley MedShare needs to achieve its healthcare transformation goals,” said Dan Burton, CEO of Health Catalyst.
By choosing Health Catalyst’s advanced data and analytics services, SacValley will enhance its ability to share and use information. This will lead to better service for those paying for healthcare, by making it easier to share important health details. This helps in delivering top-notch reports and care for patients.
“Transforming data from movable to usable is the alchemy of insights, turning raw potential into the gold of informed decision-making, ultimately forging a path towards health equity and improved outcomes,” said John Helvey, Executive Director of SacValley MedShare. “This is the primary reason SVMS chose Health Catalyst as a transforming partner.”
Another AI player is Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), which is making it easier and cheaper for other biopharma companies to produce important biological materials and organisms by using artificial intelligence (AI). Back in February 2024, Ginkgo announced the acquisition of key assets of Reverie Labs, which has built and used AI/ML tools to accelerate drug discovery. The acquisition of Reverie’s infrastructure and software serves to help train large-scale AI foundation models, while four of Reverie’s key AI team members will also be joining Ginkgo.
Gingko followed this up through a collaboration with UK-based biotech company Prozomix, to build out the production of next generation enzyme plates for active pharmaceutical ingredient (API) manufacturing. The agreement aims to leverage Gingko’s Enzyme Services and industry-leading AI/ML models along with Prozomix’s existing enzyme libraries and deep experience manufacturing enzyme plates.
“API manufacturing is poised to greatly benefit from the latest in enzyme engineering and AI/ML enzyme models,” said Cindy Chang, Senior Director, Business Development at Ginkgo Bioworks. “We are so excited to partner with Prozomix to get enzymes into as many API routes as possible and help partners meet both their COGs savings and sustainability goals.”
Another developer helping to lead the way in AI-powered healthcare is Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), which uses AI to pick out which treatments should be tested in clinical trials, while also letting biopharma companies to use their AI tools to do so also.
Last year, Recursion lined up a $50-million collaboration with AI chipmaking giant Nvidia for AI drug discovery. Then at the beginning of 2024, Recursion presented a demonstration of LOWE (Large Language Model-Orchestrated Workflow Engine), a new software designed to perform complex drug discovery tasks using a natural language interface. The platform is powered by Recursion’s proprietary biological and chemical data, and can orchestrate experiments using Recursion’s automated wet laboratories, unleashing the power of the Recursion Operating System in an easy-to-use tool.
“For the first time, we’ve taught Large Language Models to use many of Recursion’s tools and data in the same way an expert scientist would, but much more simply and in a more scalable way,” said Chris Gibson, Ph.D., Co-founder and CEO of Recursion. “LOWE provides an exciting glimpse into what we believe the future of drug discovery will look like – a first step towards the development of autonomous ‘AI scientists’ for therapeutic discovery.”
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
CONTACT:USA News [email protected]
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
View original content:https://www.prnewswire.co.uk/news-releases/ai-in-healthcare-unveiling-the-future-with-a-42-20-cagr-through-2029–302127335.html
Artificial Intelligence
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
SAN DIEGO and CALGARY, AB, April 25, 2024 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place from May 31 – June 4, 2024, in Chicago, Illinois. Details on the abstracts and poster presentation are shown below.
Title: Phase 1/2 randomized, open-label, multicenter, Simon two-stage study of pelareorep combined with modified FOLFIRINOX +/- atezolizumab in patients with metastatic pancreatic ductal adenocarcinoma.
Presentation Type: PosterAbstract Number: TPS4203Session Title: Gastrointestinal Cancer – Gastroesophageal, Pancreatic, and HepatobiliarySession Date and Time: June 1, 2024, 1:30 – 4:30 p.m. CTTitle: Pelareorep driven blood TIL expansion in patients with pancreatic, breast and colon cancer.Presentation Type: Online abstractAbstract Number: e14625
Abstracts will be published on the ASCO Annual Meeting website at 5:00 p.m. ET on May 23, 2024.
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype — turning “cold” tumors “hot” — through innate and adaptive immune responses to treat a variety of cancers.
Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid and hematological malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For further information, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.
Company Contact
Jon Patton
Director of IR & Communication
[email protected]
Investor Relations for Oncolytics
Timothy McCarthy
LifeSci Advisors
+1-917-679-9282
[email protected]
View original content:https://www.prnewswire.co.uk/news-releases/oncolytics-biotech-announces-upcoming-presentations-at-the-american-society-of-clinical-oncology-annual-meeting-302127245.html
Artificial Intelligence
Internet of Things (IoT) Market to Expand at a Stellar 19.4% CAGR through 2031 | SkyQuest Technology
WESTFORD, Mass., April 25, 2024 /PRNewswire/ — SkyQuest projects that the Internet of Things (IoT) Market will attain a value of USD 1572.37 billion by 2031, with a CAGR of 19.4% over the forecast period (2024-2031). Internet of Things (IoT) refers to the network of connected devices over the internet that are embedded with sensors and software. Growing adoption of automation around the world and advancements in connected device technologies are forecasted to be key factors driving the Internet of Things (IoT) market growth in the future.
Download a detailed overview:
https://www.skyquestt.com/report/internet-of-things-market
Browse in-depth TOC on “Internet of Things (IoT) Market”
Pages – 197Tables – 69Figures – 75Internet of Things (IoT) Market Overview:
Report Coverage
Details
Market Revenue in 2023
$ 380.6 billion
Estimated Value by 2031
$1572.37 billion
Growth Rate
Poised to grow at a CAGR of 19.4%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Component Type, Application, and Region
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the world
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Rising demand for connected healthcare and growing use of industrial automation solutions
Key Market Drivers
Advancements in connectivity and connected device technologies
Hardware is Estimated to Dominate the Global Market Share Owing to High Use of Hardware Components in IoT
Hardware components such as sensors and actuators are highly vital to the proper functioning of any kind of Internet of Things (IoT) device. Growing adoption of IoT devices in different industry verticals for various applications is promoting market growth via this segment. The development of new hardware solutions also helps this segment maintain its dominance.
Smart Agriculture is the Fastest-growing Segment Owing to Rising Adoption of Precision Agriculture Practice
Rising emphasis on improving agricultural yield and sustainability has resulted in the growing adoption of smart agriculture and precision agriculture practices. IoT devices play a crucial role in monitoring and controlling different elements of a smart agriculture setup that is mostly automated using different smart devices thereby contributing to the IoT market growth as well.
Growing Adoption of 5G Technology Allowing North America to Dominate the Global Internet of Things (IoT) Market
Rapid adoption of 5G technology and high use of cloud-based platforms are key factors allowing North America to lead the demand for Internet of Things (IoT) around the world. Surging investments in the research and development of advanced technologies and the presence of key tech giants such as Amazon, Google, IBM, and Microsoft also helps the dominance of this region. Canada and the United States remain the most lucrative markets for Internet of Things (IoT) companies in North America through 2031.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/internet-of-things-market
Internet of Things (IoT) Market Insights:
Drivers
Advancements in connectivity and connected device technologies.Growing demand for Industrial IoT (IIoT) solutions.Increasing number of smart cities and development of smart infrastructure.Restraints
Lack of standardization of IoT devices and technologies.Privacy and data security issues.Interoperability challenges and complex integration scenarios.Prominent Players in Internet of Things (IoT) Market
MicrosoftCisco SystemsIntelSiemens (Germany)AWS (US)Oracle (US)Qualcomm (UK)SAP (Germany)IBM (US)Google (US)View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/internet-of-things-market
Key Questions Answered in Internet of Things (IoT) Market Report
What are the top drivers for Internet of Things (IoT) market going forward?Who are the leading Internet of Things (IoT) market players?Where will demand for Internet of Things (IoT) be high?Which component accounts for a dominant revenue share of the global Internet of Things (IoT) market?This report provides the following insights:
Analysis of key drivers (advancements in connectivity and connected device technologies, growing demand for industrial IoT (IIoT), development of smart infrastructure for smart cities, growing use of smart devices ), restraints (lack of standardization, complexities in integration, concerns regarding security and privacy of data), and opportunities (rising popularity of connected healthcare, increasing adoption of Industry 4.0, rising use of industrial automation), influencing the growth of Internet of Things (IoT) market.Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the Internet of Things (IoT) market.Market Development: Detailed analysis of potential regions where the market has potential to grow.Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.Related Reports:
Global Internet of Things in Retail Market
Global Internet of Things (IoT) in Agriculture Market
Global Internet of Things (IoT) Microcontroller Market
Global IOT In Healthcare Market
Global IOT in Manufacturing Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh Skyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
View original content:https://www.prnewswire.co.uk/news-releases/internet-of-things-iot-market-to-expand-at-a-stellar-19-4-cagr-through-2031–skyquest-technology-302127239.html
-
Uncategorized6 days agoGenerative AI gold rush drives IT spending — with payoff in question
-
Uncategorized6 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized6 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized6 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Artificial Intelligence6 days agoFree Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
-
Uncategorized6 days ago
Can artificial intelligence reduce vehicle time to market?
-
Artificial Intelligence5 days agoAurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Uncategorized6 days ago
The Ottawa Hospital doctors to try AI for patient notes
